KEAP1 and cancer: These results indicate that NSLC01 is also active in NRF2-activated cancer cells due to genetic mutations of the components in KEAP1/NRF2 pathway but not in KEAP1 gene wild-type or immortalized normal human pancreatic ductal epithelial cells.